Clinical Trials Browser

Phase 1 × Lymphoma, Follicular × durvalumab × Clear all

NCT03610061 2024-04-12

RaDD

Phase 1 Completed

Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse

NCT03685344 2021-10-26

Safety and Antitumor Activity Study of Loncastuximab Tesirine and Durvalumab in Diffuse Large B-Cell, Mantle Cell, or Follicular Lymphoma

Phase 1 Terminated

13 enrolled 15 charts

Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell